Stock events for Bausch + Lomb Corp. (BLCO)
Bausch + Lomb's stock price has fluctuated over the past six months. Key events include a Q1 2025 earnings miss, an enVista IOL recall, fizzled buyout rumors, a Q3 2025 earnings report, and an investor day.
Demand Seasonality affecting Bausch + Lomb Corp.’s stock price
Demand for Bausch + Lomb's products is influenced by self-care trends, an aging population, and increasing eye conditions. The contact lens market is experiencing mid-single-digit growth. Seasonality and the enVista product line are expected to contribute to improved Q4 results.
Overview of Bausch + Lomb Corp.’s business
Bausch + Lomb Corporation is a global eye health company operating in the Health Care Equipment & Supplies industry. Its portfolio includes Vision Care, Pharmaceuticals, and Surgical products.
BLCO’s Geographic footprint
Bausch + Lomb has a global presence, marketing its products in approximately 100 countries across North America, South America, Europe, and Asia-Pacific/Middle East/Africa. The company also operates 24 manufacturing facilities in 10 countries.
BLCO Corporate Image Assessment
Bausch + Lomb emphasizes its history of innovation and consumer trust. The enVista IOL recall led to a securities fraud investigation, but no other specific negative events significantly impacted its overall brand reputation.
Ownership
Bausch Health Companies Inc. owns 87.65% of Bausch + Lomb's shares. Institutional shareholders hold 10.75% of the stock, while retail investors hold 0.78%.
Ask Our Expert AI Analyst
Price Chart
$16.56
